Patents/Assignees

AAVNERGENE Inc.

2 patents in portfolio

US12583907utility2026
Modified Plasma Clotting Factor VIII and Method of Use Thereof
0 cites
US11795207utility2023
Modified Plasma Clotting Factor VIII and Method of Use Thereof
0 cites